2m 2m 2m 2m 2m 2m 2m
XILIO THERAP (XLO)
NASDAQ
$8.39-$0.08 (-0.94%)
Price as of Nov 11, 2026 7:56 PM EST- $55.7MMarket Cap
- -21.76%1-Year Change
- BiotechnologyIndustry
XILIO THERAP (XLO)
$8.39-$0.08 (-0.94%)
XLO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.47 | ||
Change | -$0.06 (-0.70%) | ||
Open | $8.82 | ||
High | $8.85 | ||
Low | $8.40 | ||
Previous Close | $8.53 | ||
Volume | 3,529 | ||
30-Day Average Volume | 15,433 | ||
1-Week Change | -2.76% | ||
1-Month Change | -6.41% | ||
1-Year Change | -21.76% | ||
3-Year Change | -57.69% | ||
5-Year Change | -97.45% | ||
Fundamentals | |||
Shares Outstanding | 6.6M | ||
Total Assets | $134.8M | ||
Market Cap | $55.7M | ||
Enterprise Value | -$66.4M | ||
Period: QTR TTM FY | |||
Revenue | $10.0M | ||
Net Income | -$5.9M | ||
Free Cash Flow | -$13.9M | ||
EBIT | -$5.9M | ||
EBITDA | -$5.6M | ||
Net Working Capital | $99.7M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | 12 | ||
Enterprise Value/Revenue | -7 | ||
P/B | 1 | ||
P/E | -28 | ||
PEG | -3 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 14 | ||
Last Split Date | 03/16/2026 | ||
Earnings & Revenue